Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 1
1955 1
1957 3
1958 2
1962 1
1963 2
1964 3
1965 2
1966 6
1967 5
1968 1
1969 9
1970 6
1971 13
1972 15
1973 9
1974 7
1975 8
1976 7
1977 6
1978 5
1979 15
1980 12
1981 20
1982 19
1983 27
1984 26
1985 27
1986 26
1987 22
1988 28
1989 27
1990 34
1991 31
1992 28
1993 30
1994 28
1995 35
1996 41
1997 47
1998 48
1999 47
2000 59
2001 36
2002 51
2003 52
2004 70
2005 55
2006 58
2007 65
2008 60
2009 73
2010 92
2011 99
2012 108
2013 109
2014 128
2015 108
2016 106
2017 131
2018 124
2019 143
2020 135
2021 166
2022 164
2023 134
2024 112
2025 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,866 results

Results by year

Filters applied: . Clear all
Page 1
Gut Frailty: Its Concept and Pathogenesis.
Naito Y. Naito Y. Digestion. 2024;105(1):49-57. doi: 10.1159/000534733. Epub 2023 Nov 15. Digestion. 2024. PMID: 37967548 Free PMC article. Review.
Galectin-10 in serum extracellular vesicles reflects asthma pathophysiology.
Yoshimura H, Takeda Y, Shirai Y, Yamamoto M, Nakatsubo D, Amiya S, Enomoto T, Hara R, Adachi Y, Edahiro R, Yaga M, Masuhiro K, Koba T, Itoh-Takahashi M, Nakayama M, Takata S, Hosono Y, Obata S, Nishide M, Hata A, Yanagawa M, Namba S, Iwata M, Hamano M, Hirata H, Koyama S, Iwahori K, Nagatomo I, Suga Y, Miyake K, Shiroyama T, Fukushima K, Futami S, Naito Y, Kawasaki T, Mizuguchi K, Kawashima Y, Yamanishi Y, Adachi J, Nogami-Itoh M, Ueki S, Kumanogoh A. Yoshimura H, et al. Among authors: naito y. J Allergy Clin Immunol. 2024 May;153(5):1268-1281. doi: 10.1016/j.jaci.2023.12.030. Epub 2024 Mar 29. J Allergy Clin Immunol. 2024. PMID: 38551536 Free article.
Trastuzumab deruxtecan in patients with solid tumours harbouring specific activating HER2 mutations (DESTINY-PanTumor01): an international, phase 2 study.
Li BT, Meric-Bernstam F, Bardia A, Naito Y, Siena S, Aftimos P, Anderson I, Curigliano G, de Miguel M, Kalra M, Oh DY, Park JO, Postel-Vinay S, Rha SY, Satoh T, Spanggaard I, Michelini F, Smith A, Machado KK, Saura C; DESTINY-PanTumor01 study group. Li BT, et al. Among authors: naito y. Lancet Oncol. 2024 Jun;25(6):707-719. doi: 10.1016/S1470-2045(24)00140-2. Epub 2024 May 3. Lancet Oncol. 2024. PMID: 38710187 Clinical Trial.
Effect of Doxorubicin Plus Olaratumab vs Doxorubicin Plus Placebo on Survival in Patients With Advanced Soft Tissue Sarcomas: The ANNOUNCE Randomized Clinical Trial.
Tap WD, Wagner AJ, Schöffski P, Martin-Broto J, Krarup-Hansen A, Ganjoo KN, Yen CC, Abdul Razak AR, Spira A, Kawai A, Le Cesne A, Van Tine BA, Naito Y, Park SH, Fedenko A, Pápai Z, Soldatenkova V, Shahir A, Mo G, Wright J, Jones RL; ANNOUNCE Investigators. Tap WD, et al. Among authors: naito y. JAMA. 2020 Apr 7;323(13):1266-1276. doi: 10.1001/jama.2020.1707. JAMA. 2020. PMID: 32259228 Free PMC article. Clinical Trial.
Molecularly guided therapy versus chemotherapy after disease control in unfavourable cancer of unknown primary (CUPISCO): an open-label, randomised, phase 2 study.
Krämer A, Bochtler T, Pauli C, Shiu KK, Cook N, de Menezes JJ, Pazo-Cid RA, Losa F, Robbrecht DG, Tomášek J, Arslan C, Özgüroğlu M, Stahl M, Bigot F, Kim SY, Naito Y, Italiano A, Chalabi N, Durán-Pacheco G, Michaud C, Scarato J, Thomas M, Ross JS, Moch H, Mileshkin L. Krämer A, et al. Among authors: naito y. Lancet. 2024 Aug 10;404(10452):527-539. doi: 10.1016/S0140-6736(24)00814-6. Epub 2024 Jul 31. Lancet. 2024. PMID: 39096924 Free article. Clinical Trial.
Sema6D forward signaling impairs T cell activation and proliferation in head and neck cancer.
Hirai T, Naito Y, Koyama S, Nakanishi Y, Masuhiro K, Izumi M, Kuge T, Naito M, Mizuno Y, Yamaguchi Y, Kang S, Yaga M, Futami Y, Nojima S, Nishide M, Morita T, Kato Y, Tsuda T, Takemoto N, Kinugasa-Katayama Y, Aoshi T, Villa JK, Yamashita K, Enokida T, Hoshi Y, Matsuura K, Tahara M, Takamatsu H, Takeda Y, Inohara H, Kumanogoh A. Hirai T, et al. Among authors: naito y. JCI Insight. 2024 Feb 8;9(3):e166349. doi: 10.1172/jci.insight.166349. JCI Insight. 2024. PMID: 38329122 Free PMC article.
Exercise and functional foods.
Aoi W, Naito Y, Yoshikawa T. Aoi W, et al. Among authors: naito y. Nutr J. 2006 Jun 5;5:15. doi: 10.1186/1475-2891-5-15. Nutr J. 2006. PMID: 16749944 Free PMC article. Review.
2,866 results